Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
about
Mitogen Activated Protein kinase signal transduction pathways in the prostateCalcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic InteractionsIdentification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.Nuclear receptors and pathogenesis of pancreatic cancer.Androgen receptor signaling and mutations in prostate cancerAndrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth.Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine.Regulation of androgen receptor signaling in prostate cancer.Serum prosaposin levels are increased in patients with advanced prostate cancer.Targeted therapies for prostate cancer.Identifying environmental chemicals as agonists of the androgen receptor by using a quantitative high-throughput screening platform.Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts.Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation.RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.Predicting cancer-relevant proteins using an improved molecular similarity ensemble approach.aPKClambda/iota promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6.IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.Targeting the relaxin hormonal pathway in prostate cancer.Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels.Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9(®) to Suppress Enzalutamide-resistant Prostate Cancer Progression.Insulin-like growth factor 1 stimulation of androgen receptor activity requires β(1A) integrins.The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells.Identification of putative androgen receptor interaction protein modules: cytoskeleton and endosomes modulate androgen receptor signaling in prostate cancer cells.A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.Proteasome inhibitor PS-341 down-regulates prostate-specific antigen (PSA) and induces growth arrest and apoptosis of androgen-dependent human prostate cancer LNCaP cells.Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines.A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.The lack of Raf-1 kinase feedback regulation enhances antiapoptosis in cancer cells.Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.Coexpression of aPKCλ/ι and IL-6 in prostate cancer tissue correlates with biochemical recurrence.
P2860
Q24802614-7F8EC6BA-BE75-49EA-9FA5-EB66CB93F1C9Q26766242-76F2A522-B903-443A-9B50-7CBCCC1A8EEBQ28727939-1C74B441-4380-496E-8E32-C777CC3DF5E9Q34168476-889854FE-A049-4DFA-80D4-FA2755C890DAQ34425907-C54FB92F-249D-4D20-9104-9A57A0845672Q34714834-B5D810C8-913C-4366-A4DC-8580AFDFF306Q34947284-C5DBB984-4F41-4FB8-A0A0-A5BA42F8A5DAQ36066149-9D458735-DCF5-405C-99B5-12524132A065Q36122311-9742FEDD-BF24-4FA1-B071-6BD01E238280Q36150842-F3BA7544-717F-4F78-8EBB-A2331EAD6868Q36364970-BD674FA0-3F28-4374-A614-610769116FB2Q36429396-0128C150-E93F-4386-B011-7268101FFC32Q36446486-D3CE9401-0BDB-485F-8349-9CDC6D6BF86DQ37149065-80EEB72A-099B-4730-9821-851DB5D199D5Q37362677-371B51A4-0F53-4D86-BD1D-971096D241F0Q37364129-FCB2FDAA-7D9B-4A72-B289-6E1EFAB9DF86Q37968599-1A627CD7-E100-4AF0-9058-0DC238B18E7CQ38231840-66174D99-2DF5-4604-B512-2C003C512846Q38634034-83DBA5AD-FDFA-41E7-83DB-ED4DAB291E06Q38681329-3B7F1CC7-8EB0-4F8D-8B98-6D4F2C372275Q38739702-7B655889-6810-43C2-BA31-0E53A0A58D2FQ39491165-56A0D5CE-6FA1-4F4F-B018-67B0D0869A3BQ40217830-59201123-5236-4D6D-ADBD-9B3E7B7AB48FQ40399446-3987A556-D19C-4CED-B379-CFAF04434A81Q40579506-767A86D0-6FFF-4EBB-B7A0-5832A1B8F85CQ41497028-BB27615D-4870-4795-9EF4-55BC352174A2Q42571704-2F6BF58E-CBE8-4BC7-80B3-A055ED1FB367Q47784884-53211A58-675C-4BED-B272-018A8B672DC2Q47825566-579E2438-B7FD-4F0B-B5F7-DB30D5C85170Q51328396-8CD21735-F1A2-4263-B986-CF206283035AQ53082188-97D5AEC1-4F31-4035-8387-4548C549F60DQ54593106-8BA89CBA-6806-48C6-B4E0-8739A0A97677
P2860
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@ast
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@en
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@nl
type
label
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@ast
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@en
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@nl
prefLabel
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@ast
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@en
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@nl
P2093
P1476
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth.
@en
P2093
Alfred Hobisch
Georg Bartsch
Zoran Culig
P304
P356
10.1016/S0303-7207(02)00263-0
P577
2002-11-01T00:00:00Z